Simplify Exchange Traded Funds. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| PURECYCLE TECHNOLOGIES INCPCT | 6.89% | $24.72M | 3,048,190 |
| UNITED THERAPEUTICS CORPUTHR | 6.86% | $24.61M | 45,411 |
| NOVO NORDISK A/SNVO | 6.75% | $24.21M | 504,918 |
| ELI LILLY & COMPANYLLY | 5.91% | $21.20M | 17,678 |
| UNITEDHEALTH GROUP INCUNH | 5.76% | $20.65M | 49,695 |
| WARBY PARKER INCWRBY | 5.46% | $19.59M | 645,627 |
| JOHNSON & JOHNSONJNJ | 5.45% | $19.54M | 76,957 |
| JAZZ PHARMACEUTICALS PLC | 4.61% | $16.52M | 68,560 |
| ABBVIE INCABBV | 4.52% | $16.22M | 64,461 |
| BIOHAVEN LTD | 4.32% | $15.48M | 1,040,255 |
| BENITEC BIOPHARMA INCBNTC | 3.75% | $13.45M | 1,005,557 |
| THERMO FISHER SCIENTIFIC INCTMO | 3.23% | $11.57M | 23,079 |
| ALIGN TECHNOLOGY INCALGN | 3.14% | $11.27M | 66,847 |
| 10X GENOMICS INCTXG | 3.13% | $11.23M | 292,938 |
| QUEST DIAGNOSTICS INCDGX | 2.94% | $10.54M | 49,715 |
| GILEAD SCIENCES INCGILD | 2.87% | $10.27M | 81,325 |
| ELEVANCE HEALTH INCELV | 2.73% | $9.78M | 25,295 |
| DANAHER CORPDHR | 2.28% | $8.16M | 42,834 |
| AMGEN INCAMGN | 2.12% | $7.60M | 20,974 |
| CVS HEALTH CORPCVS | 2.01% | $7.20M | 69,556 |
| ASTRAZENECA PLC | 1.81% | $6.48M | 34,188 |
| CARDINAL HEALTH INCCAH | 1.78% | $6.40M | 26,924 |
| ESTABLISHMENT LABS HOLDINGS INC | 1.45% | $5.19M | 60,540 |
| VERTEX PHARMACEUTICALS INCVRTX | 1.45% | $5.19M | 10,456 |
| EYEPOINT INCEYPT | 1.44% | $5.17M | 361,446 |
| GUARDANT HEALTH INCGH | 1.15% | $4.14M | 27,571 |
| GE HEALTHCARE TECHNOLOGIES INCGEHC | 0.93% | $3.33M | 52,040 |
| INTUITIVE SURGICAL INCISRG | 0.83% | $2.98M | 7,492 |
| PACIRA BIOSCIENCES INCPCRX | 0.59% | $2.11M | 83,083 |
| ABBOTT LABORATORIESABT | 0.52% | $1.86M | 20,546 |
| EDWARDS LIFESCIENCES CORPEW | 0.47% | $1.69M | 18,668 |
| DREYFUS TRSY OBLIG CASH MCash or money market | 0.44% | $1.57M | 1,570,904 |
| INSMED INCINSM | 0.40% | $1.44M | 13,547 |
| TG THERAPEUTICS INCTGTX | 0.33% | $1.17M | 21,269 |
| COOPER COMPANIES INC (THE)COO | 0.26% | $945.28K | 13,182 |
| AGILON HEALTH INCAGL | 0.25% | $903.42K | 8,429 |
| STRYKER CORPSYK | 0.20% | $708.39K | 2,250 |
| BOSTON SCIENTIFIC CORPBSX | 0.18% | $640.80K | 15,014 |
| FULCRUM THERAPEUTICS INCFULC | 0.16% | $562.89K | 153,794 |
| NEUROCRINE BIOSCIENCES INCNBIX | 0.16% | $558.69K | 3,315 |
| ZIMMER BIOMET HOLDINGS INCZBH | 0.11% | $378.37K | 4,395 |
| FLUOR CORPFLR | 0.09% | $326.55K | 6,233 |
| ICON PLC | 0.07% | $260.39K | 1,499 |
| TELEFLEX INCTFX | 0.05% | $186.21K | 1,469 |
| SAREPTA THERAPEUTICS INCSRPT | 0.04% | $138.24K | 7,693 |
| PRAXIS PRECISION MEDICINES INCPRAX | 0.03% | $124.54K | 372 |
| VERALTO CORPVLTO | 0.02% | $68.11K | 768 |
| BRISTOL-MYERS SQUIBB COMPANYBMY | 0.02% | $63.38K | 1,100 |
| REGENERON PHARMACEUTICALS INCREGN | 0.01% | $48.64K | 78 |
| HEALTHEQUITY INCHQY | 0.01% | $36.49K | 404 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.